Author: wp_archive_user

[Nexa3D in Business Wire] Nexa3D Expands Global Reseller Network to Four Continents

VENTURA, Calif.–(BUSINESS WIRE)–Nexa3D,he maker of ultra-fast stereolithography production 3D printers, announced today new reseller partnerships covering the United States, Poland, Portugal, the Netherlands, Belgium and South Africa to expand its global reach to four continents. The reseller network expansion is part of Nexa3D’s ambitious plan to deliver a significant speed and productivity upgrade for the tens of thousands of legacy stereolithography printer users by delivering ultra-fast industrial printers at an attractive cost of ownership. The company’s flagship NXE400 takes current 3D printing speeds from dialup internet to broadband, breaking both the speed and productivity barriers at scale with the ability to print up to 19 liters of parts in a single build. Read...

Read More

[OurCrowd CEO Jon Medved on Fox News] Global Pandemic: Can Investing In Innovation End The Pandemic?

The ongoing coronavirus pandemic has sparked opportunity for innovation. Entrepreneurs are developing vaccines, treatments and other technological advancements in response to the virus; however, many lack the funds to do so. FOX’s Trey Yingst speaks with Jon Medved, the CEO of the investment platform OurCrowd, on how a $100 million dollar pandemic innovation fund is helping support such companies....

Read More

[SaNOtize in Business in Vancouver] Life sciences see silver lining in dark COVID clouds

If there has been a silver lining behind the otherwise menacing COVID-19 pandemic clouds for any sector of B.C.’s economy, it has been life sciences. Vancouver’s SaNOtize Research and Development Corp. had already been in Phase 2 clinical trials for a spray that uses nitric oxide to treat chronic sinusitis and had an anti-viral formulation in the pipeline. So it was well positioned for a swift pivot to test the spray as a nasal sanitizer for preventing COVID-19 infections. Read...

Read More

[Zebra in DotMed] Apollo Hospitals Group integrates Zebra Medical Vision’s AI for COVID-19 detection and disease progression tracking

While laboratory testing has served as the first line of diagnostics during the coronavirus crisis, these tests have limited accuracy and do not indicate the state of disease progression. Zebra-Med’s software offers a faster alternative for detection of COVID-19 when PCR testing is unavailable or delayed, monitoring patients with COVID-19, as decision support for the allocation of ER, ICU resources and quantifies the disease burden and its progression. Read...

Read More